newsfilter
← Latest News
GlobeNewswire·

Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction

FREEHOLD, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today